Skyhawk Therapeutics
Frank Zhang is a seasoned leader in commercial strategy and market access within the pharmaceutical industry, currently serving as Head of Commercial and Market Access at Skyhawk Therapeutics since August 2025. Zhang has a robust background with previous roles including VP of Global Value and Access at Kiniksa Pharmaceuticals and Head of Commercial at Ventyx Biosciences, emphasizing expertise in global launch strategies, market access oversight, and stakeholder engagement. Notable past positions also include leadership roles at Alnylam Pharmaceuticals and Celgene, where strategic development of pricing and market access strategies for innovative therapies was pivotal. Zhang holds a Master of Public Health from Yale University and an MD from Peking University, supplemented by advanced leadership training at Harvard Business School.
This person is not in any teams
This person is not in any offices
Skyhawk Therapeutics
1 followers
At Skyhawk Therapeutics we invent small molecules using proprietary kinetic, structural and computational models that correct RNA splicing and mis-spicing. Our small molecule platform accelerates drug development across a broad range of disease types.